Please provide your email address to receive an email when new articles are posted on . Outset Medical, maker of the Tablo hemodialysis machine, reported that the device was added to 30 new hospital ...
Outset Medical Inc. reported in a recent 8-K filing that it had received a warning letter from the FDA expressing concerns about the company’s marketing of its Tablo dialysis machine and other ...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis with its Tablo® Hemodialysis System, is ...
Outset Medical (OM) reported its Q3 2022 financial results on November 8, 2022, beating revenue and EPS estimates. The firm is commercializing a new hemodialysis machine for acute care and home ...
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling ...
Just a few months after getting back on track after pausing shipments of its Tablo hemodialysis system to secure an updated FDA clearance for at-home use of the technology, Outset Medical is facing ...
SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback